Sale of 20,000 Cohen & Steers (NYSE: CNS) shares planned under Rule 144
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
A shareholder of Cohen & Steers, Inc. filed a Rule 144 notice to sell 20,000 shares of common stock through Charles Schwab & Co., Inc. on or about February 11, 2026 on the NYSE, with an aggregate market value of $1,310,000. The filing notes that 51,007,541 shares of this class were outstanding. These shares were originally acquired on January 31, 2019 via a restricted stock lapse treated as equity compensation from Cohen & Steers, Inc. The signer represents they are unaware of undisclosed material adverse information about the issuer.
Positive
- None.
Negative
- None.
FAQ
What does the Form 144 filing for CNS disclose?
The Form 144 discloses a planned sale of 20,000 CNS common shares. A Cohen & Steers, Inc. shareholder intends to sell these shares on or about February 11, 2026 on the NYSE, with an aggregate market value of $1,310,000 under Rule 144.
What is the approximate sale date in the CNS Form 144 filing?
The approximate sale date stated is February 11, 2026. The shareholder indicates an intention to sell 20,000 common shares of Cohen & Steers, Inc. on or around that date on the New York Stock Exchange through Charles Schwab & Co., Inc.
What representation does the seller make in the CNS Form 144?
The seller represents they know no undisclosed material adverse information. By signing the notice, they state they are unaware of material adverse information about Cohen & Steers’ current or prospective operations that has not already been publicly disclosed.